N-acetylaspartate metabolism in neural cells

Advances in Experimental Medicine and Biology

Volumn 576, Issue , 2006, Pages 27-47

  Bhakoo, Kishore K ^b   Craig, Timothy ^b   Pearce, Daniel ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934439276     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-30172-0_3     Document Type: Conference Paper

References (97)

1. H.H. Tallan, S. Moore, and W.H. Stein, N-acetyl-L-aspartic acid in brain, J. Biol. Chem. 219, 257-264 (1956).
2. T.B. Patel and J.B. Clark, Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport, Biochem. J. 184, 539-546 (1979).
3. 1H-MRS studies in vivo, Neuroreport 7, 1397-400 (1996).
4. J.V. Nadler and J.R. Cooper, N-Acetyl-L-aspartic acid content of human neural tumours and bovine periperal nervous tissues, J. Neurochem. 19, 313-319 (1972).
5. K.J. Koller, R. Zaczek, and J.T. Coyle, N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method, J. Neurochem. 43, 1136-42 (1984).
6. J.R. Moffett, M.A. Namboodiri, C.B. Cangro, and J.H. Neale, Immunohistochemical localization of N-acetylaspartate in rat brain, Neuroreport 2, 131-4 (1991).
7. M.L. Simmons, C.G. Frondoza, and J.T. Coyle, Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies, Neuroscience 45, 37-45 (1991).
8. J. Urenjak, S.R. Williams, D.G. Gadian, and M. Noble, Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro, J. Neurochem. 59, 55-61 (1992).
9. J. Urenjak, S.R. Williams, D.G. Gadian, and M. Noble, Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types, J. Neurosci. 13, 981-9 (1993).
10. H. Shigematsu, N. Okamura, H. Shimeno, Y. Kishimoto, L. Kan, and C. Fenselau, Purification and characterization of the heat-stable factors essential for the conversion of lignoceric acid to cerebronic acid and glutamic acid: identification of N-acetyl-L-aspartic acid, J. Neurochem. 40, 814-820 (1983).
11. A.F.J. D'Adamo and F.M. Yatsu, Acetate metabolism in the nervous system. N-acetyl-L-aspartic acid and the biosynthesis of brain lipids, J. Neurochem. 13, 961-5 (1966).
12. A.F.J. D'Adamo, L.I. Gidez, and F.M.J. Yatsu, Acetyl transport mechanisms. Involvement of N-acetyl aspartic acid in de novo fatty acid biosynthesis in the developing rat brain, Exp. Brain Res. 5, 267-73 (1968).
13. J.C. McIntosh and J.R. Cooper, Studies on the function of N-acetyl-L-aspartic acid in brain, J. Neurochem. 12, 825-835 (1965).
14. 1H-NMR spectroscopic studies of brain, Neurosci. Biobehav. Rev. 13, 23-31 (1989).
15. N. De Stefano, P.M. Matthews, and D.L. Arnold, Reversible decreases in N-acetyl-aspartate after acute brain injury, Magn. Reson. Med. 34, 721-7 (1995).
16. N.R. Jagannathan, N. Tandon, P. Raghunathan, and N. Kochupillai, Reversal of abnormalities of myelination by thyroxine therapy in congenital hypothyroidism: localized in vivo proton magnetic resonance spectroscopy (MRS) study, Dev. Brain Res. 109, 179-86 (1998).
17. M. Mayer, K. Bhakoo, and M. Noble, Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro, Development 120, 143-53 (1994).
18. B.A. Barres, J.F. Burne, B. Holtmann, H. Thoenen, M. Sendtner, and M.C. Raff, Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation, Mol. Cell Neurosci. 8, 146-56 (1996).
19. S.M. Birnbaum, Amino acid acylases I and II from Hog Kidney, Methods in Enzymology 2, 115-119 (1955).
20. R. Kaul, G.P. Gao, M. Aloya, K. Michals, and R. Matalon, Identification of mutations in human aspartoacylase (hasp) gene in Canavan disease, Am. J. Hum. Genetics 53, 215-215 (1993).
21. M.M. Canavan, Schildler's encephalitis periaxialsis diffusa, Arch. Neurol. Psychiatry 25, 299-308 (1931).
22. L. Hagenfeldt, I. Bollgren, and N. Venizelos, N-acetylaspartic aciduria due to aspartoacylase deficiency - a new aetiology of childhood leukodystrophy, J. Inherit. Metab. Disease 10, 135-141 (1987).
23. R. Matalon, R. Kaul, J. Casanova, K. Michals, A. Johnson, I. Rapin, P. Gashkoff, and M. Deanching, Aspartoacylase deficiency: The enzyme defect in Canavan disease, J. Inherit. Metab. Disease 12, 329-331 (1989).
24. R. Burri, C. Steffen, and N. Herschkowitz, N-acetyl-L-Aspartate is a major source of acetyl groups for lipid synthesis during rat brain development, Dev. Neurosci. 13, 403-411 (1991).
25. M.H. Baslow and T.R. Resnik, Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms, J. Mol. Neurosci. 9, 109-25 (1997).
26. T.N. Sager, C. Thomsen, J.S. Valsborg, H. Laursen, and A.J. Hansen, Astroglia contain a specific transport mechanism for N-acetyl-L-aspartate, J. Neurochem. 73, 807-11 (1999).
27. F.B. Goldstein, The enzymatic synthesis of N-acetyl-L-aspartic acid by subcellular preparations of rat brain, J. Biol. Chem. 244, 4257-60 (1969).
28. C.B. Cangro, M.A. Namboodiri, L.A. Sklar, A. Corigliano Murphy, and J.H. Neale, Immunohistochemistry and biosynthesis of N-acetylaspartylglutamate in spinal sensory ganglia, J. Neurochem. 49, 1579-88 (1987).
29. L. Ory Lavollee, R.D. Blakely, and J.T. Coyle, Neurochemical and immunocytochemical studies on the distribution of N-acetyl-aspartylglutamate and N-acetyl-aspartate in rat spinal cord and some peripheral nervous tissues, J. Neurochem. 48, 895-9 (1987).
30. W. Grodd, I. Krageloh Mann, D. Petersen, F.K. Trefz, and K. Harzer, In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy [letter], Lancet 336, 437-8 (1990).
31. D.S. Dunlop, D.M. Mchale, and A. Lajtha, Decreased brain N-Acetyl-aspartate in huntingtons disease, Brain Research 580, 1-2 (1992).
32. 1H magnetic resonance spectroscopic imaging, Neurology 43, 509-15 (1993).
33. P. Gideon, O. Henriksen, B. Sperling, P. Christiansen, T.S. Olsen, H.S. Jorgensen, and P. Arliensoborg, Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke - a proton magnetic-resonance spectroscopy study, Stroke 23, 1566-1572 (1992).
34. R. Kaul, K. Michals, J. Casanova, and R. Matalon, The role of N-acetylaspartic acid in brain metabolism and the pathogenesis in Canavan disease, Intl. Pediat. 6, 40-43 (1991).
35. S. Confort-Gouny, J. Vion-Dury, F. Nicoli, P. Dano, A. Donnet, N. Grazziani, J.L. Gastaut, F. Grisoli, and P.J. Cozzone, A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases, J. Neurol. Sci. 118, 123-33 (1993).
36. A.F.J. D'Adamo, J.C. Smith, and C. Woiler, The occurrence of N-acetylaspartate amidohydrolase (aminoacylase II) in the developing rat, J. Neurochem. 20, 1275-8 (1973).
37. 1H-NMR spectroscopy and high performance liquid chromatography, Neurochem. Res. 21, 1065-74 (1996).
38. R. Kaul, J. Casanova, A.B. Johnson, P. Tang, and R. Matalon, Purification, characterization, and localization of aspartoacylase from bovine brain, J. Neurochem. 56, 129-35 (1991).
39. M.H. Baslow, R.F. Suckow, V. Sapirstein, and B.L. Hungund, Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes, J. Mol. Neurosci. 13, 47-53 (1999).
40. K.K. Bhakoo and D. Pearce, In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo, J. Neurochem. 74, 254-62 (2000).
41. K.K. Bhakoo, T.J. Craig, and P. Styles, Developmental and regional distribution of aspartoacylase in rat brain tissue, J. Neurochem. 79, 211-20 (2001).
42. J.H. Bottenstein and G.H. Sato, Growth of a rat neuroblastoma cell line in serum-free supplemented medium, Proc. Natl. Acad. Sci. U.S.A. 76, 514-517 (1979).
43. P.F. Bartlett, M.D. Noble, R.M. Pruss, M.C. Raff, S. Rattray, and C.A. Williams, Rat neural antigen-2 (RAN-2): a cell surface antigen on astrocytes, ependymal cells, Muller cells and lepto-meninges defined by a monoclonal antibody, Brain Res. 204, 339-51 (1981).
44. B. Ranscht, P.A. Clapshaw, J. Price, M. Noble, and W. Seifert, Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside, Proc. Natl. Acad. Sci. U.S.A. 79, 2709-13 (1982).
45. G.S. Eisenbarth, F.S. Walsh, and M. Nirenberg, Monoclonal antibody to a plasma membrane antigen of neurons, Proc. Natl. Acad. Sci. U.S.A. 76, 4913-7 (1979).
46. O. Bogler, D. Wren, S.C. Barnett, H. Land, and M. Noble, Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells, Proc. Natl. Acad. Sci. U.S.A. 87, 6368-72 (1990).
47. M.C. Raff, R. Mirsky, K.L. Fields, R.P. Lisak, S.H. Dorfman, D.H. Silberberg, N.A. Gregson, S. Leibowitz, and M.C. Kennedy, Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture, Nature 274, 813-816 (1978).
48. M. Noble and K. Murray, Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell, EMBO J. 3, 2243-7 (1984).
49. K.K. Bhakoo, I.T. Williams, S.R. Williams, D.G. Gadian, and M.D. Noble, Proton nuclear magnetic resonance spectroscopy of primary cells derived from nervous tissue, J. Neurochem. 66, 1254-63 (1996).
50. J.N. Wood and B.H. Anderton, Monoclonal antibodies to mammalian neurofilaments, Biosci. Rep. 1, 263-8 (1981).
51. K.J. Koller and J.T. Coyle, Ontogenesis of N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in rat brain, Brain Res. 317, 137-40 (1984).
52. O.H. Lowry, N.J. Rosenbrough, and A.L. Farr, Protein measurement with the Folin phenol regent, J. Biol. Chem. 193, 265-275 (1951).
53. 1H-NMR spectroscopy for three types of human brain and nervous system tumours, NMR Biomed. 8, 253-64 (1995).
54. K.A. Stockli, L.E. Lillien, M. Naher Noe, G. Breitfeld, R.A. Hughes, M.C. Raff, H. Thoenen, and M. Sendtner, Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain, J. Cell Biol. 115, 447-59 (1991).
55. B.A. Barres, I.K. Hart, H.S. Coles, J.F. Burne, J.T. Voyvodic, W.D. Richardson, and M.C. Raff, Cell death and control of cell survival in the oligodendrocyte lineage, Cell 70, 31-46 (1992).
56. B.A. Barres, R. Schmid, M. Sendnter, and M.C. Raff, Multiple extracellular signals are required for long-term oligodendrocyte survival, Development 118, 283-95 (1993).
57. H.H. Tallan, Studies on the distribution of N-acetyl-L-aspartic acid in brain, J. Biol. Chem. 224, 41-5 (1957).
58. 31P NMR spectroscopy of the developing rat brain], Hokkaido Igaku Zasshi 67, 272-80 (1992).
59. T. Kato, M. Nishina, K. Matsushita, E. Hori, T. Mito, and S. Takashima, Neuronal maturation and N-acetyl-L-aspartic acid development in human fetal and child brains, Brain Dev. 19, 131-3 (1997).
60. P.B. Toft, Metabolite concentrations in the developing brain estimated with proton MR spectroscopy, J. Magn. Reson. Imaging 4, 674-680 (1994).
61. A.F.J. D'Adamo and A.P. D'Adamo, Acetyl transport mechanisms in the nervous system. The oxoglutarate shunt and fatty acid synthesis in the developing rat brain, J. Neurochem. 15, 315-23 (1968).
62. F.A. McMorris and R.D. McKinnon, Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease, Brain Pathol. 6, 313-29 (1996).
63. C.S. Raine, The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion, J. Neuroimmunol. 77, 135-52 (1997).
64. C.F. Lucchinetti, W. Brueck, M. Rodriguez, and H. Lassmann, Multiple sclerosis: lessons from neuropathology, Semin. Neurol. 18, 337-49 (1998).
65. L. Zhou, B.D. Trapp, and R.H. Miller, Demyelination in the central nervous system mediated by an anti-oligodendrocyte antibody, J. Neurosci. Res. 54, 158-68 (1998).
66. C.A. Davie, C.P. Hawkins, G.J. Barker, A. Brennan, P.S. Tofts, D.H. Miller, and W.I. McDonald, Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions, Brain 117, 49-58 (1994).
67. T.L. Richards, Proton MR spectroscopy in multiple-sclerosis - value in establishing diagnosis, monitoring progression, and evaluating therapy, Am. J. Roentgenol. 157, 1073-1078 (1991).
68. N. De Stefano, P.M. Matthews, S. Narayanan, G.S. Francis, J.P. Antel, and D.L. Arnold, Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient, Neurology 49, 1138-41 (1997).
69. P.A. Narayana, T.J. Doyle, D. Lai, and J.S. Wolinsky, Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis, Ann. Neurol. 43, 56-71 (1998).
70. P.M. Matthews, E. Pioro, S. Narayanan, N. De Stefano, L. Fu, G. Francis, J. Antel, C. Wolfson, and D.L. Arnold, Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy, Brain 119, 715-22 (1996).
71. L. Fu, P.M. Matthews, N. De Stefano, K.J. Worsley, S. Narayanan, G.S. Francis, J.P. Antel, C. Wolfson, and D.L. Arnold, Imaging axonal damage of normal-appearing white matter in multiple sclerosis, Brain 121, 103-13 (1998).
72. H. Sugie, S. Tsurui, A. Ishikawa, F. Matsuda, Y. Sugie, Y. Igarashi, and Y. Fujise, [Effects of neonatal hypothyroidism on brain development: analysis of brain metabolites using high resolution phosphorus and proton magnetic resonance (NMR) spectroscopy]. [Article in Japanese], No To Hattatsu. 22, 166-72 (1990).
73. M.J. Malone, N.P. Rosman, M. Szoke, and D. Davis, Myelination of brain in experimental hypothyroidism. An electron-microscopic and biochemical study of purified myelin isolates, J. Neurol. Sci. 26, 1-11 (1975).
74. J.M. Matthieu, P.J. Reier, and J.A. Sawchak, Proteins of rat brain myelin in neonatal hypothyroidism, Brain Res. 84, 443-51 (1975).
75. T. Valcana, E.R. Einstein, J. Csejtey, K.B. Dalal, and P.S. Timiras, Influence of thyroid hormones on myelin proteins in the developing rat brain, J. Neurol. Sci. 25, 19-27 (1975).
76. R.A. Harris and H.H. Loh, Brain sulfatide and non-lipid sulfate metabolism in hypothyroid rats, Res. Commun. Chem. Pathol. Pharmacol. 24, 169-179 (1979).
77. J.M. Pasquini, I.A. Faryna-de-Raveglia, N. Capitman, and E.F. Soto, Neonatal hypothyroidism and early undernutrition in the rat: defective maturation of structural membrane components in the central nervous system, Neurochem. Res. 6, 979-91 (1981).
78. T. Noguchi, T. Sugisaki, I. Satoh, and M. Kudo, Partial restoration of cerebral myelination of the congenitally hypothyroid mouse by parenteral or breast milk administration of thyroxine, J. Neurochem. 45, 1419-26 (1985).
79. G. Almazan, P. Honegger, and J.M. Matthieu, Triiodothyronine stimulation of oligodendroglial differentiation and myelination. A developmental study, Dev. Neurosci. 7, 45-51 (1985).
80. G. Shanker, S.G. Amur, and R.A. Pieringer, Investigations on myelinogenesis in vitro: a study of the critical period at which thyroid hormone exerts its maximum regulatory effect on the developmental expression of two myelin associated markers in cultured brain cells from embryonic mice, Neurochem. Res. 10, 617-25 (1985).
81. S.P. Porterfield and C.E. Hendrich, The role of thyroid hormones in prenatal and neonatal neurological development - current perspectives, Endocr. Rev. 14, 94-106 (1993).
82. N. Ibarrola, M. Mayer-Proschel, A. Rodriguez-Pena, and M. Noble, Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro, Dev. Biol. 180, 1-21 (1996).
83. S.C. Ahlgren, H. Wallace, J. Bishop, C. Neophytou, and M.C. Raff, Effects of thyroid hormone on embryonic oligodendrocyte precursor cell development in vivo and in vitro, Mol. Cell Neurosci. 9, 420-32 (1997).
84. F.B. Gao, J. Apperly, and M. Raff, Cell-intrinsic timers and thyroid hormone regulate the probability of cell-cycle withdrawal and differentiation of oligodendrocyte precursor cells, Dev. Biol. 197, 54-66 (1998).
85. C. Bjartmar, J. Battistuta, N. Terada, E. Dupree, and B.D. Trapp, N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve, Ann. Neurol. 51, 51-8 (2002).
86. M. Noble and G. Wolswijk, Development and regeneration in the O-2A lineage: studies in vitro and in vivo, J. Neuroimmunol 40, 287-93 (1992).
87. M.C. Raff, Glial cell diversification in the rat optic nerve, Science 243, 1450-5 (1989).
88. M.C. Raff, C. Ffrench Constant, and R.H. Miller, Glial cells in the rat optic nerve and some thoughts on remyelination in the mammalian CNS, J. Exp Biol. 132, 35-41 (1987).
89. P.C. Brunjes, A comparative study of prenatal development in the olfactory bulb, neocortex and hippocampal region of the precocial mouse Acomys cahirinus and rat, Dev. Brain Res. 49, 7-25 (1989).
90. A.K. Groves, A. Entwistle, P.S. Jat, and M. Noble, The characterization of astrocyte cell lines that display properties of glial scar tissue, Dev. Biol. 159, 87-104 (1993).
91. C.A. Haas, U. Rauch, N. Thon, T. Merten, and T. Deller, Entorhinal cortex lesion in adult rats induces the expression of the neuronal chondroitin sulfate proteoglycan neurocan in reactive astrocytes, J. Neurosci. 19, 9953-63 (1999).
92. R.J. McKeon, M.J. Jurynec, and C.R. Buck, The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar, J. Neurosci. 19, 10778-88 (1999).
93. V. Gallo and A. Bertolotto, Extracellular matrix of cultured glial cells: selective expression of chondroitin 4-sulfate by type-2 astrocytes and their progenitors, Exp. Cell Res. 187, 211-23 (1990).
94. K. Kitada, T. Akimitsu, Y. Shigematsu, A. Kondo, T. Maihara, N. Yokoi, T. Kuramoto, M. Sasa, and T. Serikawa, Accumulation of N-acetyl-L-aspartate in the brain of the tremor rat, a mutant exhibiting absence-like seizure and spongiform degeneration in the central nervous system, J. Neurochem. 74, 2512-9 (2000).
95. T. Akimitsu, K. Kurisu, R. Hanaya, K. Iida, Y. Kiura, K. Arita, H. Matsubayashi, K. Ishihara, K. Kitada, T. Serikawa, and M. Sasa, Epileptic seizures induced by N-acetyl-L-aspartate in rats: in vivo and in vitro studies, Brain Res. 861, 143-50 (2000).
96. N. De Stefano, P.M. Matthews, L. Fu, S. Narayanan, J. Stanley, G.S. Francis, J.P. Antel, and D.L. Arnold, Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study, Brain 121, 1469-77 (1998).
97. C.N. Madhavarao, J.R. Moffett, R.A. Moore, R.E. Viola, M.A. Namboodiri, and D.M. Jacobowitz, Immunohistochemical localization of aspartoacylase in the rat central nervous system, J. Comp. Neurol. 472, 318-29 (2004).